1.
YULIANI SH. NANOPARTICLE AS THE STRATEGY FOR THE DEVELOPMENT OF SARS-COV-2 ANTIVIRAL DRUGS. Int J App Pharm [Internet]. 2021 Sep. 7 [cited 2024 Nov. 22];13(5):33-4. Available from: https://journals.innovareacademics.in/index.php/ijap/article/view/42604